Jackson Orem
Experienced in Anemia

Jackson Orem

Upper Mulago Hill Road, 
Kampala, C, UG 
Experienced in Anemia
Upper Mulago Hill Road, 
Kampala, C, UG 
OverviewLocationsClinical Research

Overview

Jackson Orem practices in Kampala, Uganda. Mr. Orem is rated as an Experienced expert by MediFind in the treatment of Anemia. His top areas of expertise are Burkitt Lymphoma, Kaposi Sarcoma, B-Cell Lymphoma, Tissue Biopsy, and Gastrostomy.

His clinical research consists of co-authoring 140 peer reviewed articles and participating in 3 clinical trials. MediFind looks at clinical research from the past 15 years. In particular, he has co-authored 4 articles in the study of Anemia.

Gender
Male

Locations

Upper Mulago Hill Road, Kampala, C, Uganda
Other Locations
Upper Mulago Hill Rd, Kampala, C, Uganda

Clinical Research

Clinical research consists of overseeing clinical studies of patients undergoing new treatments and therapies, and publishing articles in peer reviewed medical journals. Experts who actively participate in clinical research are generally at the forefront of the fields and aware of the most up-to-date advances in treatments for their patients.

3 Clinical Trials

A Pilot Study of Nelfinavir for the Treatment of Kaposi Sarcoma
A Pilot Study of Nelfinavir for the Treatment of Kaposi Sarcoma
Enrollment Status: Completed
Publish Date: April 30, 2024
Intervention Type: Other, Drug
Study Drug: Nelfinavir Mesylate
Study Phase: Phase 2
A Phase I Study of Subcutaneous Rituximab Hyaluronidase Combined With Local Standard-of-Care Chemotherapy for the Treatment of Burkitt Lymphoma, Diffuse Large B-Cell Lymphoma or as Monotherapy for Kaposi Sarcoma Herpesvirus Associated Multicentric Castleman Disease in Pediatrics and Adults in Uganda
A Phase I Study of Subcutaneous Rituximab Hyaluronidase Combined With Local Standard-of-Care Chemotherapy for the Treatment of Burkitt Lymphoma, Diffuse Large B-Cell Lymphoma or as Monotherapy for Kaposi Sarcoma Herpesvirus Associated Multicentric Castleman Disease in Pediatrics and Adults in Uganda
Enrollment Status: Terminated
Publish Date: January 03, 2024
Intervention Type: Drug, Biological
Study Drugs: Rituximab and Hyaluronidase Human, Cyclophosphamide, Vincristine, Methotrexate, Doxorubicin, Doxorubicin Hydrochloride, Prednisone, Etoposide, Rituximab
Study Phase: Phase 1
Defining the Molecular Profile of Breast Cancer in Uganda and Its Clinical Implications
Defining the Molecular Profile of Breast Cancer in Uganda and Its Clinical Implications
Enrollment Status: Completed
Publish Date: June 08, 2022
Intervention Type: Drug, Procedure
Study Drugs: Cyclophosphamide, Methotrexate, Capecitabine
Study Phase: Phase 1
View 2 Less Clinical Trials

140 Total Publications

Impact of Waiting Time and Treatment Duration on Short-Term Outcomes for Patients With Locally Advanced Cervical Cancer at the Uganda Cancer Institute: The Challenges in Resource-Limited Settings.
Impact of Waiting Time and Treatment Duration on Short-Term Outcomes for Patients With Locally Advanced Cervical Cancer at the Uganda Cancer Institute: The Challenges in Resource-Limited Settings.
Journal: JCO global oncology
Published: October 08, 2025

Areas of Expertise

MediFind evaluates expertise by pulling from factors such as number of articles a doctor has published in medical journals, participation in clinical trials, speaking at industry conferences, prescribing and referral patterns, and strength of connections with other experts in their field.

Learn more about MediFind’s expert tiers

Find Mr. Orem's expertise for a condition
ConditionClose
    View All 20 Experienced Conditions
    Want to save this expert for later?
    Sign Up
    Not sure about your diagnosis?
    Check Your Symptoms
     
     
     
     
    Learn about our expert tiers
    Learn More
    Are you the provider on this profile?
    Claim Profile